Brief: Olema Oncology Announces FDA Clearance Of Investigational New Drug Application For OP-3136
09/12/2024 12:15
Dec 9 (Reuters) - Olema Pharmaceuticals Inc OLMA.O :
* OLEMA ONCOLOGY ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL
NEW
DRUG APPLICATION FOR OP-3136, A POTENT KAT6 INHIBITOR
* OLEMA PHARMACEUTICALS INC - PHASE 1 CLINICAL TRIAL FOR
OP-3136
TO START EARLY 2025
Source text: ID:nGNX8Vj6ws
Further company coverage: OLMA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Olema Oncology
See all newsBrief: Olema Pharmaceuticals Changes Corporate Name To Olema Oncology, Effective Today
Olema Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings Summary
Olema Pharma Q3 net loss widens on higher costs
Brief: Olema Pharmaceuticals Q3 Net Income USD -73.599 Million
Olema Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary